The weekly litigation news digest is live. Subscribe now

IP Verse

Individualized Vaccines For Cancer - EP3892295

The patent EP3892295 was granted to Biontech on Apr 26, 2023. The application was filed on May 23, 2012 under application number EP21168360A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3892295

BIONTECH
Application Number
EP21168360A
Filing Date
May 23, 2012
Status
Opposition Rejected
May 29, 2025
Publication Date
Apr 26, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
WITHERS & ROGERS LLPJONES NICHOLASWRIGHT HOWARD WALLIN NICHOLASJan 25, 2024TOMBLINGADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2006EP09448
DESCRIPTIONWO9633739
DESCRIPTIONWO9724447
OPPOSITIONWO0119408
OPPOSITIONWO03051401
OPPOSITIONWO03059381
OPPOSITIONWO2010037539
SEARCHWO2011143656

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents